1.Alinejad S, Kazemi T, Zamani N, Hoffman RS, Mehrpour O. A systematic review of the cardiotoxicity of methadone. EXCLI journal. 2015; 14:577.
2.Alinejad S, Zamani N, Abdollahi M, Mehrpour O. A narrative review of acute adult poisoningin Iran. Iranian journal of medical sciences. 2017;42(4):327.
3.Graham NA, Merlo LJ, Goldberger BA, Gold MS. Methadone- and heroin-related deaths in Florida. Am J Drug Alcohol Abuse. 2008;34(3):347‐353.
4.Dart RC, Bronstein AC, Spyker DA, Cantilena LR, Seifert SA, Heard SE, et al. Poisoning in the United States: 2012 emergency medicine report of the National Poison Data System. Annals of emergency medicine. 2015;65(4):416-22.
5.Akhgari M, Amini‐Shirazi N, Iravani FS. Forensic Toxicology Perspectives of Methadone‐associated Deaths in Tehran, Iran, a 7‐year Overview. Basic & clinical pharmacology & toxicology. 2018;122(4):436-41.
6.Thanavaro KL, Thanavaro JL. Methadone-induced torsades de pointes: a twist of fate. Heart & Lung: The Journal of Acute and Critical Care. 2011;40(5):448-53.
7. Alderks CE. Trends in the Use of Methadone, Buprenorphine, and Extended-Release Naltrexone at Substance Abuse Treatment Facilities: 2003-2015 (Update). In: The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013:1‐8.
8.Wax PM, Kleinschmidt KC, Brent J, ACMT ToxIC Case Registry Investigators. The toxicology investigators consortium (ToxIC) registry. Journal of Medical Toxicology. 2011 Dec 1;7(4):259-65.
9.Monte AA, Calello DP, Gerona RR, Hamad E, Campleman SL, Brent J, Wax P, Carlson RG, ACMT Toxicology Investigators Consortium. Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC database study. Journal of Medical Toxicology. 2017 Jun 1;13(2):146-52.
10. Rhyee SH, Farrugia L, Wiegand T, Smith EA, Wax PM, Brent J; Toxicology Investigators Consortium. The toxicology investigators consortium case registry-the 2013 experience. J Med Toxicol. 2014 Dec;10(4):342-59.
11.Modesto-Lowe V, Brooks D, Petry N. Methadone deaths: risk factors in pain and addicted populations. J Gen Intern Med. 2010 Apr;25(4):305-9. doi: 10.1007/s11606-009-1225-0. Epub 2010 Jan 20. PMID: 20087676; PMCID: PMC2842557.
12. Inocencio TJ, Carroll NV, Read EJ, Holdford DA. The economic burden of opioid-related poisoning in the United States. Pain Med. 2013 Oct;14(10): 1534-47.doi: 10.1111/pme.12183.
13. Tedesco D, Asch SM, Curtin C, Hah J, McDonald KM, Fantini MP, Hernandez-Boussard T. Opioid Abuse And Poisoning: Trends In Inpatient And Emergency Department Discharges. Health Aff (Millwood). 2017 Oct 1;36(10):1748-1753.
14.Cicero TJ, Inciardi JA. Diversion and abuse of methadone prescribed for pain management. JAMA.2005;293(3):297-298. doi: 10.1001/jama.293.3.297
15.Office of the Press Secretary [Internet]. Washington (DC): WhiteHouse. Press release, Fact sheet: President Obama proposes $1.1 billionin new funding to address the prescription opioid abuse and heroin use epidemic; 2016 Feb 2 [cited2017 Jul 19]. Available from: https://obamawhitehouse.archives.gov/thepress-office/2016/02/02/presidentobama-proposes-11-billion-newfunding-address-prescription
16.Dowell D, Haegerich TM, Chou R.CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep.2016;65(1):1–49.
17.American Medical Association. Reversing the opioid epidemic [Internet].Chicago (IL): AMA; [cited 2017Jul 19]. Available from: https://www.ama-assn.org/delivering-care/reversing-opioid-epidemic
18. Center for control disease and prevention (CDC), USS Opioid Prescribing Rate Maps. Available at: https://www.cdc.gov/drugoverdose/maps/rxrate-maps.html
19. Ray WA, Chung CP, Murray KT, Cooper WO, Hall K, Stein CM. Out-of-hospital mortality among patients receiving methadone for noncancer pain. JAMA Intern Med.2015 Mar;175(3):420-7.
20. Gummin DD, Mowry JB, Spyker DA, Brooks DE, Osterthaler KM, Banner W. 2017 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 35th Annual Report. Clin Toxicol (Phila). 2018 Dec;56(12):1213-1415.
21. Fox LM, Hoffman RS, Vlahov D, Manini AF. Risk factors for severe respiratory depression from prescription opioid overdose. Addiction. 2018 Jan;113(1):59-66. doi: 10.1111/add.13925. Epub 2017 Sep 6. PMID: 28646524; PMCID: PMC5725269.
22. Zedler BK, Saunders WB, Joyce AR, Vick CC, Murrelle EL. Validation of a Screening Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in a US Commercial Health Plan Claims Database. Pain Med. 2017
23.Alinejad S, Ghaemi K, Abdollahi M, Mehrpour O. Nephrotoxicity of methadone: a systematic review. Springerplus. 2016 Dec 9;5(1):2087. doi:10.1186/s40064-016-3757-1. eCollection 2016.
24.Bertol E, Bigagli L, D'Errico S, Mari F, Palumbo D, Pascali JP, Vaiano F. Analysis of illicit drugs seized in the Province of Florence from 2006 to 2016. Forensic Sci Int. 2018 Mar; 284:194-203. doi: 10.1016/j.forsciint.2018.01.010
25. Kazemi Roodsari S, Bahramnejad E, Rahimi N, Aghaei I, Dehpour AR. Methadone's effects on pentylenetetrazole-induced seizure threshold in mice: NMDA/opioid receptors and nitric oxide signaling. Ann N Y Acad Sci. 2019;1449(1):25‐35. doi:10.1111/nyas.14043
26.Aghabiklooei A, Edalatparvar M, Zamani N, Mostafazadeh B. Prognostic factors in acute methadone toxicity: a 5-year study. J Toxicol. 2014; 2014:341826.
27.Brent J, Burkhart K, Dargan P, Hatten B, Megarbane B, Palmer R & White J. (Eds.). Critical care toxicology: diagnosis and management of the critically poisoned patient. Springer, 2017.